Pierre Fabre Appoints Venaig Solinhac as CEO of Dermo-Cosmetics Division
Laboratoires Pierre Fabre has announced the appointment of Venaig Solinhac as CEO of its Dermo-Cosmetics and Personal Care division.
Venaig Solinhac has been appointed as the new CEO of Pierre Fabre's Dermo-Cosmetics and Personal Care division. This move marks a significant development in the company's leadership, with Solinhac bringing over 20 years of international experience in driving growth and transformation for global leaders in consumer healthcare, consumer goods, and venture capital.
Solinhac has held key executive positions at Kenvue, including Global Vice President of Baby Care and Vice President of Essential Health Asia Pacific. In these roles, she was involved in the global relaunch of Johnson's Baby, the revitalization of Listerine in Asia-Pacific, and the rollout of large-scale digital and commercial acceleration programs.
Prior to joining Kenvue, Solinhac spent 15 years at GlaxoSmithKline Consumer Healthcare, where she held local, regional, and global leadership roles across four continents. During her tenure, she led transformative portfolio and digitalization initiatives, contributing to the growth of major brands such as Sensodyne, Panadol, Centrum, and Parodontax.
## New Leadership for Pierre Fabre's Dermo-Cosmetics Division
As the CEO of Pierre Fabre's Dermo-Cosmetics and Personal Care division, Solinhac will oversee the implementation of the brand strategy for the division, which includes Eau Thermale Avène, Ducray, A-Derma, Klorane, René Furterer, Darrow, MÊME Cosmetics, and Pierre Fabre Oral Care.
The division generated EUR 1.711 billion in revenue in 2025, up 2.6% year on year and 4.4% at constant exchange rates.
Eric Ducournau, CEO of Laboratoires Pierre Fabre, expressed his confidence in Solinhac's ability to accelerate the company's growth, stating that "The dermo-cosmetics market is growing faster than other segments, and Pierre Fabre is positioned as one of the global leaders in this sector, with brands recognized and recommended by doctors and pharmacists worldwide."
Solinhac's ambition is to build on the company's remarkable legacy by working with the teams to develop even more specialized and innovative brands, helping more consumers around the world care for their skin, hair, and oral health.
| Revenue (EUR billion) | Year-on-Year Growth | Constant Exchange Rate Growth | | --- | --- | --- | | 1.711 | 2.6% | 4.4% |
Solinhac's appointment marks a significant development in the company's leadership, and her experience and expertise are expected to drive growth and transformation in the Dermo-Cosmetics and Personal Care division.
